Results 231 to 240 of about 51,741 (305)

Cutaneous reaction to BNT162b2 mRNA COVID‐19 vaccine [PDF]

International Journal of Dermatology, 2021
Alba López‐Valle, Daniel Falkenhain‐López, Celia Ruiz‐Arranz   +2 more
openaire   +3 more sources

Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine [PDF]

, 2021
Jose W. Ricardo, Shari R. Lipner
openalex   +1 more source

Decline of immune humoral response after BNT162b2 vaccine

Journal of Infection, 2022
Sonia Ferri, Alessandro Polidoro, Marco Ciacciarelli, Umberto Ceratti, Viviana Congedo, Maria Mele, Graziella Coluzzi, Alessandra Spagnoli, Luigi Iuliano   +8 more
openaire   +4 more sources

Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up [PDF]

, 2023
Noam Barda, Yaniv Lustig, Victoria Indenbaum, Daniel Zibly, Gili Joseph, Keren Asraf, Yael Weiss-Ottolenghi, Sharon Amit, Limor Kliker, Bayan Abd Elkader, Eytan Ben‐Ami, Michal Canetti, Ravit Koren, Shiri Katz-Likvornik, Osnat Halpern, Ella Mendelson, Ram Doolman, Dror Harats, Yitshak Kreiss, Michal Mandelboim, Gili Regev‐Yochay   +20 more
openalex   +1 more source

Evolution of Antibody Titers Up to 6 Months Post-Immunization With the BNT162b2 Pfizer/BioNTech Vaccine in Greece

, 2021
Κωνσταντίνα Κοντοπούλου, Christos T. Nakas, Alexandra Ainatzoglou, Georgia Goudi, Christos Katsioulis, Georgios Papazisis   +5 more
openalex   +1 more source

Humoral and Cellular Response and Associated Variables Nine Months following BNT162b2 Vaccination in Healthcare Workers [PDF]

, 2023
Natalia Syrimi, Flora Sourri, Maria-Christina Giannakopoulou, Dimitrios Karamanis, Asterios Pantousas, Persefoni Georgota, Eleni Rokka, Zoe Vladeni, Euaggelia Tsiantoula, Evangelia Soukara, Nikoletta Lavda, Dimitrios Gkaragkanis, Aikaterini Zisaki, Panagiotis Vakalidis, Vasiliki Goula, Evdokia Loupou, Leonidas Palaiodimos, Dimitrios Hatzigeorgiou   +17 more
openalex   +1 more source

Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules:exploratory analyses of Com-COV, a randomised control trial [PDF]

, 2022

core   +1 more source

Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine

Nature Medicine, 2021
M. Levine-Tiefenbrun, I. Yelin, R. Katz, E. Herzel, Z. Golan, L. Schreiber, T. Wolf, V. Nadler, A. Ben-Tov, J. Kuint, S. Gazit, T. Patalon, G. Chodick, R. Kishony   +13 more
semanticscholar   +1 more source

Frosted branch angiitis after booster vaccination with BNT162b2

Journal Français d'Ophtalmologie, 2023
Haas, A.-M., Stattin, M., Barisani-Asenbauer, T., Krepler, K., Ansari-Shahrezaei, S.   +4 more
openaire   +2 more sources

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

The Lancet Oncology, 2021
L. Monin, Adam G. Laing, M. Muñoz-Ruiz, Duncan R. McKenzie, Irene del Molino del Barrio, T. Alaguthurai, C. Domingo-Vila, T. Hayday, C. Graham, J. Seow, Sultan Abdul-Jawad, S. Kamdar, E. Harvey-Jones, R. Graham, J. Cooper, Muhammad Khan, Jennifer Vidler, H. Kakkassery, Shubhankar Sinha, Richard Davis, L. Dupont, I. Francos Quijorna, Charlotte O’Brien-Gore, Puay Ling Lee, J. Eum, María Conde Poole, Magdalene Joseph, Daniel Davies, Yin Wu, A. Swampillai, B. North, A. Montes, M. Harries, A. Rigg, J. Spicer, M. Malim, P. Fields, P. Patten, F. Di Rosa, S. Papa, T. Tree, K. Doores, A. Hayday, Sheeba Irshad   +43 more
semanticscholar   +1 more source